51 results
S-3ASR
EX-4.2
d1hnd7gn58bsjmbrmnxm
24 Nov 23
Automatic shelf registration
9:30am
S-3ASR
EX-4.1
82rki 5siqv
24 Nov 23
Automatic shelf registration
9:30am
8-K
EX-99.1
urmlbpn z7
3 Aug 23
Intellia Therapeutics Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress
7:45am
DEFA14A
2c7acm
5 Jun 23
Additional proxy soliciting materials
5:16pm
8-K
EX-99.1
mmqdxj
5 Jun 23
Departure of Directors or Certain Officers
4:52pm
8-K
EX-99.1
dumrx x4i8h
4 May 23
Intellia Therapeutics Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
7:41am
PRE 14A
1346dw
18 Apr 23
Preliminary proxy
4:16pm
8-K
EX-99.1
n1im tcpah1
17 Apr 23
Intellia Therapeutics Names Bill Chase to its Board of Directors
4:59pm
8-K
EX-1.1
dyh 920e4ao
1 Dec 22
Entry into a Material Definitive Agreement
5:22pm